{"database": "openregs", "table": "dockets", "rows": [["FDA-2005-N-0345", "FDA", "Distribution of Blood Derivatives by Registered Blood Establishments that Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures (Section 610 Review)", "Rulemaking", "2022-01-05T01:02:18Z", "0b00006480449858"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-N-0345"], "units": {}, "query_ms": 0.4440599586814642, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}